EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS
In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance...
Ausführliche Beschreibung
Autor*in: |
S S Rodionova [verfasserIn] T N Turgumbayev [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch ; Russisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Остеопороз и остеопатии - Endocrinology Research Centre, 2018, 16(2013), 1, Seite 24-28 |
---|---|
Übergeordnetes Werk: |
volume:16 ; year:2013 ; number:1 ; pages:24-28 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.14341/osteo2013124-28 |
---|
Katalog-ID: |
DOAJ005995094 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ005995094 | ||
003 | DE-627 | ||
005 | 20230309195210.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.14341/osteo2013124-28 |2 doi | |
035 | |a (DE-627)DOAJ005995094 | ||
035 | |a (DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a rus | ||
050 | 0 | |a RZ301-397.5 | |
100 | 0 | |a S S Rodionova |e verfasserin |4 aut | |
245 | 1 | 0 | |a EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. | ||
650 | 4 | |a остеопороз | |
650 | 4 | |a эндопротезирование тазобедренного сустава | |
650 | 4 | |a алендронат | |
650 | 4 | |a альфакальцидол | |
650 | 4 | |a коррекция интенсивности резорбции и костеобразования | |
653 | 0 | |a Osteopathy | |
700 | 0 | |a T N Turgumbayev |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Остеопороз и остеопатии |d Endocrinology Research Centre, 2018 |g 16(2013), 1, Seite 24-28 |w (DE-627)1760648779 |x 23110716 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2013 |g number:1 |g pages:24-28 |
856 | 4 | 0 | |u https://doi.org/10.14341/osteo2013124-28 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8 |z kostenfrei |
856 | 4 | 0 | |u https://endojournals.ru/index.php/osteo/article/view/8845 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2072-2680 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2311-0716 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 16 |j 2013 |e 1 |h 24-28 |
author_variant |
s s r ssr t n t tnt |
---|---|
matchkey_str |
article:23110716:2013----::fetflnrntcmiewtafcliooteilgcltbltohponedpoteii |
hierarchy_sort_str |
2013 |
callnumber-subject-code |
RZ |
publishDate |
2013 |
allfields |
10.14341/osteo2013124-28 doi (DE-627)DOAJ005995094 (DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. остеопороз эндопротезирование тазобедренного сустава алендронат альфакальцидол коррекция интенсивности резорбции и костеобразования Osteopathy T N Turgumbayev verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 16(2013), 1, Seite 24-28 (DE-627)1760648779 23110716 nnns volume:16 year:2013 number:1 pages:24-28 https://doi.org/10.14341/osteo2013124-28 kostenfrei https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8845 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 16 2013 1 24-28 |
spelling |
10.14341/osteo2013124-28 doi (DE-627)DOAJ005995094 (DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. остеопороз эндопротезирование тазобедренного сустава алендронат альфакальцидол коррекция интенсивности резорбции и костеобразования Osteopathy T N Turgumbayev verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 16(2013), 1, Seite 24-28 (DE-627)1760648779 23110716 nnns volume:16 year:2013 number:1 pages:24-28 https://doi.org/10.14341/osteo2013124-28 kostenfrei https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8845 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 16 2013 1 24-28 |
allfields_unstemmed |
10.14341/osteo2013124-28 doi (DE-627)DOAJ005995094 (DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. остеопороз эндопротезирование тазобедренного сустава алендронат альфакальцидол коррекция интенсивности резорбции и костеобразования Osteopathy T N Turgumbayev verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 16(2013), 1, Seite 24-28 (DE-627)1760648779 23110716 nnns volume:16 year:2013 number:1 pages:24-28 https://doi.org/10.14341/osteo2013124-28 kostenfrei https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8845 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 16 2013 1 24-28 |
allfieldsGer |
10.14341/osteo2013124-28 doi (DE-627)DOAJ005995094 (DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. остеопороз эндопротезирование тазобедренного сустава алендронат альфакальцидол коррекция интенсивности резорбции и костеобразования Osteopathy T N Turgumbayev verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 16(2013), 1, Seite 24-28 (DE-627)1760648779 23110716 nnns volume:16 year:2013 number:1 pages:24-28 https://doi.org/10.14341/osteo2013124-28 kostenfrei https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8845 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 16 2013 1 24-28 |
allfieldsSound |
10.14341/osteo2013124-28 doi (DE-627)DOAJ005995094 (DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. остеопороз эндопротезирование тазобедренного сустава алендронат альфакальцидол коррекция интенсивности резорбции и костеобразования Osteopathy T N Turgumbayev verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 16(2013), 1, Seite 24-28 (DE-627)1760648779 23110716 nnns volume:16 year:2013 number:1 pages:24-28 https://doi.org/10.14341/osteo2013124-28 kostenfrei https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8845 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 16 2013 1 24-28 |
language |
English Russian |
source |
In Остеопороз и остеопатии 16(2013), 1, Seite 24-28 volume:16 year:2013 number:1 pages:24-28 |
sourceStr |
In Остеопороз и остеопатии 16(2013), 1, Seite 24-28 volume:16 year:2013 number:1 pages:24-28 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
остеопороз эндопротезирование тазобедренного сустава алендронат альфакальцидол коррекция интенсивности резорбции и костеобразования Osteopathy |
isfreeaccess_bool |
true |
container_title |
Остеопороз и остеопатии |
authorswithroles_txt_mv |
S S Rodionova @@aut@@ T N Turgumbayev @@aut@@ |
publishDateDaySort_date |
2013-01-01T00:00:00Z |
hierarchy_top_id |
1760648779 |
id |
DOAJ005995094 |
language_de |
englisch russisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ005995094</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309195210.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14341/osteo2013124-28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ005995094</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RZ301-397.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S S Rodionova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеопороз</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">эндопротезирование тазобедренного сустава</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">алендронат</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">альфакальцидол</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">коррекция интенсивности резорбции и костеобразования</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Osteopathy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T N Turgumbayev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Остеопороз и остеопатии</subfield><subfield code="d">Endocrinology Research Centre, 2018</subfield><subfield code="g">16(2013), 1, Seite 24-28</subfield><subfield code="w">(DE-627)1760648779</subfield><subfield code="x">23110716</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:24-28</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14341/osteo2013124-28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://endojournals.ru/index.php/osteo/article/view/8845</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2072-2680</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2311-0716</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="h">24-28</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
S S Rodionova |
spellingShingle |
S S Rodionova misc RZ301-397.5 misc остеопороз misc эндопротезирование тазобедренного сустава misc алендронат misc альфакальцидол misc коррекция интенсивности резорбции и костеобразования misc Osteopathy EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS |
authorStr |
S S Rodionova |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760648779 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RZ301-397 |
illustrated |
Not Illustrated |
issn |
23110716 |
topic_title |
RZ301-397.5 EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS остеопороз эндопротезирование тазобедренного сустава алендронат альфакальцидол коррекция интенсивности резорбции и костеобразования |
topic |
misc RZ301-397.5 misc остеопороз misc эндопротезирование тазобедренного сустава misc алендронат misc альфакальцидол misc коррекция интенсивности резорбции и костеобразования misc Osteopathy |
topic_unstemmed |
misc RZ301-397.5 misc остеопороз misc эндопротезирование тазобедренного сустава misc алендронат misc альфакальцидол misc коррекция интенсивности резорбции и костеобразования misc Osteopathy |
topic_browse |
misc RZ301-397.5 misc остеопороз misc эндопротезирование тазобедренного сустава misc алендронат misc альфакальцидол misc коррекция интенсивности резорбции и костеобразования misc Osteopathy |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Остеопороз и остеопатии |
hierarchy_parent_id |
1760648779 |
hierarchy_top_title |
Остеопороз и остеопатии |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1760648779 |
title |
EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS |
ctrlnum |
(DE-627)DOAJ005995094 (DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8 |
title_full |
EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS |
author_sort |
S S Rodionova |
journal |
Остеопороз и остеопатии |
journalStr |
Остеопороз и остеопатии |
callnumber-first-code |
R |
lang_code |
eng rus |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
txt |
container_start_page |
24 |
author_browse |
S S Rodionova T N Turgumbayev |
container_volume |
16 |
class |
RZ301-397.5 |
format_se |
Elektronische Aufsätze |
author-letter |
S S Rodionova |
doi_str_mv |
10.14341/osteo2013124-28 |
author2-role |
verfasserin |
title_sort |
effect of alendronate combined with alfacalcidol on the biological stability of hip joint endoprosthesis in patients with systemic osteoporosis |
callnumber |
RZ301-397.5 |
title_auth |
EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS |
abstract |
In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. |
abstractGer |
In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. |
abstract_unstemmed |
In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
container_issue |
1 |
title_short |
EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS |
url |
https://doi.org/10.14341/osteo2013124-28 https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8 https://endojournals.ru/index.php/osteo/article/view/8845 https://doaj.org/toc/2072-2680 https://doaj.org/toc/2311-0716 |
remote_bool |
true |
author2 |
T N Turgumbayev |
author2Str |
T N Turgumbayev |
ppnlink |
1760648779 |
callnumber-subject |
RZ - Other Systems of Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.14341/osteo2013124-28 |
callnumber-a |
RZ301-397.5 |
up_date |
2024-07-03T18:21:14.398Z |
_version_ |
1803583094154854401 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ005995094</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309195210.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14341/osteo2013124-28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ005995094</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcdd0123d6aa24e82b5171410fcb979e8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RZ301-397.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S S Rodionova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In a comparative study we investigated the influence of a combination of alendronate and alfacalcidol on the dynamics of bone mass density (BMD) at the site attached to the femoral component of endoprosthesis in total hip replacement in patients with systemic osteoporosis. Evaluation of performance of pharmacotherapy in the postoperative period on osteoporosis, systemic osteoporosis, sustained BMD deficit at Gruen regions confirmed that the essential component of osteointegration at the «implant-bone» site during the period of physiological adaptive remodeling after arthroplasty in women suffering from systemic osteoporosis is the pharmacological correction of the intensity of bone resorption in post-operative period.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеопороз</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">эндопротезирование тазобедренного сустава</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">алендронат</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">альфакальцидол</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">коррекция интенсивности резорбции и костеобразования</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Osteopathy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T N Turgumbayev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Остеопороз и остеопатии</subfield><subfield code="d">Endocrinology Research Centre, 2018</subfield><subfield code="g">16(2013), 1, Seite 24-28</subfield><subfield code="w">(DE-627)1760648779</subfield><subfield code="x">23110716</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:24-28</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14341/osteo2013124-28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cdd0123d6aa24e82b5171410fcb979e8</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://endojournals.ru/index.php/osteo/article/view/8845</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2072-2680</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2311-0716</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="h">24-28</subfield></datafield></record></collection>
|
score |
7.4009905 |